Screen-detected vs clinical breast cancer: the advantage in the relative risk of lymph node metastases decreases with increasing tumour size
2005

Reply on Tumour Size and Overdiagnosis in Breast Cancer

publication Evidence: moderate

Author Information

Author(s): L Bucchi, A Barchielli, A Ravaioli, M Federico, V De Lisi, S Ferretti, E Paci, M Vettorazzi, S Patriarca, A Frigerio, E Buiatti, SCREENREG Working Group

Primary Institution: Romagna Cancer Registry, Forlì, Italy

Hypothesis

The relative protection of screen-detected tumours from the risk of nodal involvement decreases with increasing size.

Conclusion

The findings suggest that the biological aggressiveness of most breast cancers increases as they develop in size.

Supporting Evidence

  • The relative risk of nodal involvement for screen-detected tumours increased with size.
  • Only a small subset of screen-detected cancers have a relatively stable biological indolence.
  • The findings await confirmation as they are unique in the literature.

Takeaway

This study looks at how the size of breast tumours found during screening affects their risk of spreading, showing that bigger tumours are often more aggressive.

Methodology

A multiple regression model was built to analyze the interaction between detection mode and tumour size.

Potential Biases

Potential biases related to the interpretation of overdiagnosis and length time bias were discussed.

Limitations

The study does not address all methodological concerns raised by critics.

Statistical Information

P-Value

0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6602583

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication